Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis
Biomedical Reports · 12.06.2026 · 25 (2) · 1-15
DOI: 10.3892/br.2026.2165 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Biomedical Reports, online erschienen am 12.06.2026. Verfasst von Yanhua Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Emergency Department of Dongying People's Hospital, Dongying, Shandong 257092, P.R. China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Emergency Department of Dongying People's Hospital, Dongying, Shandong 257092, P.R. China.
Zitieren
APA
Li, Y., Lv, C., Cao, L., Lihua, S., & Ma, Y. (2026). Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis. Biomedical Reports, 25(2), 1-15. https://doi.org/10.3892/br.2026.2165
Vancouver
Li Y, Lv C, Cao L, Lihua S, Ma Y. Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis. Biomedical Reports. 2026;25(2):1-15. doi:10.3892/br.2026.2165
BibTeX
@article{Li2026,
author = {Li, Yanhua and Lv, Chunmei and Cao, Lianlian and Lihua, Sun and Ma, Yanqu},
title = {Semaglutide and major adverse cardiovascular events in patients with and without DM: A systematic review and meta‑analysis},
journal = {Biomedical Reports},
year = {2026},
volume = {25},
number = {2},
pages = {1--15},
doi = {10.3892/br.2026.2165}
}
EUVIMED